Nagy, C F <br/><br/>
Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule.  [electronic resource] 

 -  Clinical and translational science  01 2017 
 - 12-19 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1752-8062 
<br/><br/><label>Standard No.: </label>10.1111/cts.12433  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthrax--drug therapy<br/>Antibodies, Monoclonal--administration & dosage<br/>Antitoxins--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Macaca fascicularis<br/>Rabbits<br/>Respiratory Tract Infections--drug therapy<br/>Time Factors<br/>Translational Research, Biomedical<br/>United States<br/>United States Food and Drug Administration